Erosive Esophagitis
📧 Sign up to get email alerts when something new happens for Erosive Esophagitis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2025-04-15FDA Approved: ESOMEPRAZOLE MAGNESIUM — Original Application (Aurobindo Pharma Limited)
FDA approved an original application for Esomeprazole Magnesium from Aurobindo Pharma Limited, adding a generic esomeprazole magnesium produ…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM DELAYED-RELEASE DELAYED RELEASE — Original Application (Cipla USA Inc.)
FDA approves Cipla USA Inc.'s pantoprazole sodium delayed-release granules as an original generic pantoprazole product (ANDA 217458) for aci…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Alembic Pharmaceuticals Limited)
FDA approved Alembic Pharmaceuticals Limited's original application for pantoprazole sodium injection, adding a new generic injectable panto…
-
FDA approval · 2025-03-31FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for Pantoprazole Sodium from Aurobindo Pharma Limited, making a generic pantoprazole available. The pr…
-
CLINICAL_TRIALS trial_result · 2025-03-25Clinical Trial Update: A Study to Evaluate Vonoprazan Concentrations in Breast Milk of Healthy Lactating Women Receiving Vonoprazan 20 mg Once Daily or Vonoprazan 20 mg Twice Daily [Phase 1]
Phase 1 study evaluating vonoprazan concentrations in breast milk of healthy lactating women given 20 mg once daily or 20 mg twice daily; re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals Limited's esomeprazole magnesium for delayed-release oral suspension via an original ANDA, confirming b…
-
FDA approval · 2025-03-05FDA Approved: ESOMEPRAZOLE MAGNESIUM FOR DELAYED-RELEASE ORAL SUSPENSION — Original Application (Torrent Pharmaceuticals Limited)
FDA approved Torrent Pharmaceuticals' esomeprazole magnesium delayed-release oral suspension via an original application, providing a generi…
-
FDA approval · 2025-01-16FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Rising Pharma Holdings, Inc.)
The FDA approved the original abbreviated new drug application for pantoprazole sodium from Rising Pharma Holdings, enabling the generic pro…
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (Medcore LLC)
The FDA approved a supplemental application for lansoprazole from Medcore LLC, enabling a generic lansoprazole product to be marketed under …
-
FDA approval · 2024-12-19FDA Approved: LANSOPRAZOLE — Supplemental Application (NorthStar Rx LLC)
The FDA approved a supplemental application for lansoprazole submitted by NorthStar Rx LLC.
-
CLINICAL_TRIALS research · 2024-12-17Clinical Trial Update: Indonesian Study of Vonoprazan Vs Esomeprazole in Erosive Esophagitis [Phase 4]
An Indonesian Phase 4 trial comparing vonoprazan to esomeprazole for erosive esophagitis is not yet recruiting.
-
FDA approval · 2024-12-10FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Ascend Laboratories, LLC)
FDA approved a supplemental application for esomeprazole magnesium from Ascend Laboratories, LLC, under an approved ANDA.
-
FDA approval · 2024-11-27FDA Approved: PANTOPRAZOLE SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for pantoprazole sodium from Amneal Pharmaceuticals LLC, updating the approval for this generic prot…
-
FDA approval · 2024-11-12FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for esomeprazole magnesium from Mylan Pharmaceuticals, enabling the generic product to be marketed w…
-
FDA approval · 2024-11-08FDA Approved: GOOD NEIGHBOR PHARMACY OMEPRAZOLE — Supplemental Application (Amerisource Bergen)
FDA approved a supplemental application for Good Neighbor Pharmacy Omeprazole (omeprazole) submitted by Amerisource Bergen.
-
FDA approval · 2024-11-08FDA Approved: ACID REDUCER — Supplemental Application (WALGREEN CO.)
FDA approves a supplemental application for ACID REDUCER (omeprazole) from Walgreens Co., under ANDA206877.
-
FDA approval · 2024-11-07FDA Approved: CIMETIDINE — Original Application (Bionpharma Inc.)
FDA approved Bionpharma Inc.'s Original Application for cimetidine, enabling the marketing of a generic H2 blocker. The action establishes a…
-
FDA approval · 2024-11-04FDA Approved: LANSOPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved a generic version of lansoprazole via an Original Abbreviated New Drug Application for Macleods Pharmaceuticals Limited.
-
FDA approval · 2024-10-23FDA Approved: ESOMEPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
FDA approved Esomeprazole under an Original Application for Macleods' generic product, enabling generic market access.
-
FDA label_change · 2024-09-16FDA Approved: LANSOPRAZOLE — Supplemental Application (Zydus Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lansoprazole from Zydus Pharmaceuticals USA Inc., resulting in updated labeling for the prod…
-
CLINICAL_TRIALS trial_result · 2024-08-27Clinical Trial Update: JP-1366 20mg Versus Esomeprazole 40mg in Patients With Erosive Esophagitis [Phase 3]
A Phase 3 trial comparing JP-1366 20 mg with esomeprazole 40 mg in patients with erosive esophagitis has completed.
-
FDA approval · 2024-08-20FDA Approved: FAMOTIDINE — Supplemental Application (Baxter Healthcare Corporation)
FDA approved Baxter Healthcare Corporation's supplemental application for famotidine (ANDA075591), granting approval for the generic product…
-
FDA approval · 2024-08-06FDA Approved: FAMOTIDINE — Original Application (Novadoz Pharmaceuticals LLC)
FDA approved the original ANDA application for famotidine from Novadoz Pharmaceuticals LLC, enabling a generic version of famotidine to reac…
-
FDA approval · 2024-08-01FDA Approved: PANTOPRAZOLE SODIUM — Original Application (Fresenius Kabi USA, LLC)
FDA approved Pantoprazole sodium from Fresenius Kabi USA as an original application (ANDA) generic product.
-
FDA approval · 2024-07-17FDA Approved: ESOMEPRAZOLE MAGNESIUM — Supplemental Application (Somerset Therapeutics, LLC)
FDA approved a supplemental application for esomeprazole magnesium by Somerset Therapeutics, LLC.